Clinical Trials Directory

Trials / Sponsors / Nuvalent Inc.

Nuvalent Inc.

Industry · 6 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Phase 32025-07-17
RecruitingA Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 12024-07-18
RecruitingA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrange
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 22022-06-09
RecruitingA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearra
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1 / Phase 22022-01-04
AvailableExpanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumo
Non Small Cell Lung Cancer, ALK-positive Non-small Cell Lung Cancer (NSCLC)
——
AvailableExpanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid
Non Small Cell Lung Cancer, ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
——